MARKET

KAPA

KAPA

KAIROS PHARMA LTD
AMEX
1.670
-0.010
-0.60%
Opening 11:48 09/11 EDT
OPEN
1.687
PREV CLOSE
1.680
HIGH
1.753
LOW
1.670
VOLUME
9.20K
TURNOVER
--
52 WEEK HIGH
14.77
52 WEEK LOW
1.510
MARKET CAP
5.65M
P/E (TTM)
-0.8576
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KAPA last week (0831-0904)?
Weekly Report · 4d ago
Weekly Report: what happened at KAPA last week (0824-0828)?
Weekly Report · 08/31 10:09
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 08/27 21:07
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 08/24 17:06
Karios Pharma Hits 52-Week Low; Buzz Builds Around Reverse Split And Pipeline Milestone
NASDAQ · 08/24 14:15
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 08/24 12:06
Weekly Report: what happened at KAPA last week (0817-0821)?
Weekly Report · 08/24 10:09
Stock Market Today: S&P 500, Nasdaq 100 Futures Slip Ahead of Data-Heavy Week, Nvidia Earnings, and Jackson Hole—BABA, PMI, BIRK in Focus
Benzinga · 08/24 09:30
More
About KAPA
Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company. The Company is engaged in advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. Its therapy includes antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. Its portfolio consists of seven drug therapies consisting of peptide and small molecule cancer immunotherapeutics KROS 101, 102, 201, 301 and 401 and therapeutic agents ENV 105 and 205. KROS 101 is a small molecule that targets the glucocorticoid-induced tumor necrosis factor ligand-related (GITR) ligand, a signal for T cell growth to remove a checkpoint barrier to fight a host of cancers. KROS 201 is a T cell therapy activated by dendritic cells to treat glioblastoma, a deadly and common brain cancer. ENV 105 drug seeks to address unmet medical needs in large markets of prostate and lung cancers.

Webull offers Kairos Pharma Ltd stock information, including AMEX: KAPA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KAPA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KAPA stock methods without spending real money on the virtual paper trading platform.